Helen of Troy Earnings Calls
| Release date | Jul 09, 2026 |
| EPS estimate | $0.0200 |
| EPS actual | - |
| Revenue estimate | 374.554M |
| Revenue actual | - |
| Expected change | +/- 10.11% |
| Release date | Apr 23, 2026 |
| EPS estimate | $0.660 |
| EPS actual | $0.83 |
| EPS Surprise | 25.76% |
| Revenue estimate | 450.502M |
| Revenue actual | 470.025M |
| Revenue Surprise | 4.33% |
| Release date | Jan 08, 2026 |
| EPS estimate | $1.71 |
| EPS actual | $1.71 |
| Revenue estimate | 504.377M |
| Revenue actual | 512.829M |
| Revenue Surprise | 1.68% |
| Release date | Oct 09, 2025 |
| EPS estimate | $0.540 |
| EPS actual | $0.590 |
| EPS Surprise | 9.26% |
| Revenue estimate | 508.422M |
| Revenue actual | 431.781M |
| Revenue Surprise | -15.07% |
Last 4 Quarters for Helen of Troy
Below you can see how HELE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 09, 2025 |
| Price on release | $20.71 |
| EPS estimate | $0.540 |
| EPS actual | $0.590 |
| EPS surprise | 9.26% |
| Date | Price |
|---|---|
| Oct 03, 2025 | $26.44 |
| Oct 06, 2025 | $26.32 |
| Oct 07, 2025 | $27.01 |
| Oct 08, 2025 | $27.61 |
| Oct 09, 2025 | $20.71 |
| Oct 10, 2025 | $20.60 |
| Oct 13, 2025 | $19.51 |
| Oct 14, 2025 | $20.73 |
| Oct 15, 2025 | $19.73 |
| 4 days before | -21.67% |
| 4 days after | -4.73% |
| On release day | -0.531% |
| Change in period | -25.38% |
| Release date | Jan 08, 2026 |
| Price on release | $20.58 |
| EPS estimate | $1.71 |
| EPS actual | $1.71 |
| Date | Price |
|---|---|
| Jan 02, 2026 | $20.61 |
| Jan 05, 2026 | $20.77 |
| Jan 06, 2026 | $21.76 |
| Jan 07, 2026 | $21.06 |
| Jan 08, 2026 | $20.58 |
| Jan 09, 2026 | $19.40 |
| Jan 12, 2026 | $18.78 |
| Jan 13, 2026 | $18.67 |
| Jan 14, 2026 | $19.05 |
| 4 days before | -0.170% |
| 4 days after | -7.41% |
| On release day | -5.74% |
| Change in period | -7.57% |
| Release date | Apr 23, 2026 |
| Price on release | $23.82 |
| EPS estimate | $0.660 |
| EPS actual | $0.83 |
| EPS surprise | 25.76% |
| Date | Price |
|---|---|
| Apr 17, 2026 | $18.86 |
| Apr 20, 2026 | $19.78 |
| Apr 21, 2026 | $20.27 |
| Apr 22, 2026 | $19.77 |
| Apr 23, 2026 | $23.82 |
| Apr 24, 2026 | $23.62 |
| Apr 27, 2026 | $23.39 |
| Apr 28, 2026 | $23.45 |
| Apr 29, 2026 | $23.82 |
| 4 days before | 26.30% |
| 4 days after | 0% |
| On release day | -0.84% |
| Change in period | 26.30% |
| Release date | Jul 09, 2026 |
| Price on release | - |
| EPS estimate | $0.0200 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 15, 2026 | $28.79 |
| Jun 16, 2026 | $28.60 |
| Jun 17, 2026 | $26.47 |
| Jun 18, 2026 | $26.47 |
| Jun 22, 2026 | $26.00 |
Helen of Troy Earnings Call Transcript Summary of Q1 2026
Helen of Troy reported a disappointing Q1 fiscal 2026 with consolidated net sales down 10.8% (organic down 17.3% ex‑Olive & June). Management attributes roughly 8 percentage points of the decline to tariff-related disruptions (cancellations, pull‑forward into Q4 FY25, and softness/competition in China) plus broader demand softness and consumer trade‑down (3%–4% price compression in the U.S.). GAAP operating loss was large due to noncash impairment charges; adjusted EPS was $0.41 vs. $0.99 prior year. Management (Interim CEO Brian Grass and Interim CFO Tracy Shereman) outlined five priorities: restore confidence and execution, simplify/go‑to‑market, refocus on product‑driven innovation and sharper marketing, return to fundamentals and brand differentiation, and reinvigorate culture. Key near‑term actions: accelerate supply‑chain diversification and dual‑sourcing out of China, implement targeted price increases (average 7%–10% across the portfolio, with individual moves up to ~15%), and take cost/cash preservation measures (suspend noncritical capex, hiring reductions, marketing prioritization). The company is guiding Q2 net sales of $408–$432 million (decline 14%–9%) and adjusted EPS $0.45–$0.60. They are not giving full‑year guidance due to ongoing tariff uncertainty. Inventory ended Q1 at $484M (includes $14M of tariff costs and Olive & June inventory); inventory is expected to rise to ~$510–$520M by Q2 end (seasonality, Olive & June, ~$35M tariff costs). The company expects most direct tariff costs to hit in H2 FY26 but believes mitigation and pricing will substantially reduce net operating income impact; they now estimate diversification will cut U.S. import tariff exposure to ~25% of COGS by end FY26 and ~15% by end FY27. Management emphasized returning to fundamentals, improving execution speed, and using a leaner cost structure to protect liquidity and resume profitable growth.
Sign In
Buy HELE